| 000 | 01395 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516052927.0 | ||
| 264 | 0 | _c20111221 | |
| 008 | 201112s 0 0 eng d | ||
| 022 | _a1474-5488 | ||
| 024 | 7 |
_a10.1016/S1470-2045(11)70222-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCollins, Ian M | |
| 245 | 0 | 0 |
_aThe tubal hypothesis of ovarian cancer: caution needed. _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _cNov 2011 |
||
| 300 |
_a1089-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBRCA1 Protein _xgenetics |
| 650 | 0 | 4 |
_aBRCA2 Protein _xgenetics |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 |
_aFallopian Tubes _xpathology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGerm-Line Mutation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aOvariectomy _xadverse effects |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSalpingectomy _xadverse effects |
| 650 | 0 | 4 | _aTranslational Research, Biomedical |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDomchek, Susan M | |
| 700 | 1 | _aHuntsman, David G | |
| 700 | 1 | _aMitchell, Gillian | |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 12 _gno. 12 _gp. 1089-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(11)70222-4 _zAvailable from publisher's website |
| 999 |
_c21110906 _d21110906 |
||